Inhibrx Biosciences, Inc. (INBX) income statement
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$68.97−5.36 (-7.21%)
Close on Nov 20, 2026Market cap $1.02BP/E –Yield –
Inhibrx Biosciences, Inc. financial ratios
See a number that looks wrong?